Baicalin reduces inflammation to inhibit lung cancer via targeting SOCS1/NF-κB/STAT3 axis.
Baicalin, a compound from Georgi, inhibits lung cancer progression by reducing inflammation and targeting SOCS1/NF-κB/STAT3 pathway. Potential novel treatment for lung cancer.
- Guo L et al (2024).
- Heliyon.
- PubMed:
- 38628726